Peroxisome Proliferator-Activated Receptor-Gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Pioglitazone (Primary)
- Indications Atherosclerosis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms RAPPAR
- 31 Aug 2018 Biomarkers information updated
- 28 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 28 Oct 2013 Primary endpoint 'Flow-mediated-dilation' has not been met.